Lindbrook Capital’s CryoPort CYRX Stock Holding History

Lindbrook Capital’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$2.19K	Sell	361 -352	-49%	-$2.44K	﹤0.01%	2252
2024 Q4	$5.55K	Sell	713 -44	-6%	-$328	﹤0.01%	1937
2024 Q3	$6.14K	Buy	757 +695	+1,121%	+$5.69K	﹤0.01%	1924
2024 Q2	$428	Buy	+62	New	+$835	﹤0.01%	2658
2023 Q3	–	Sell	-114	Closed	-$1.97K	–	2717
2023 Q2	$1.97K	Sell	114 -37	-25%	-$757	﹤0.01%	2152
2023 Q1	$3.62K	Sell	151 -38	-20%	-$826	﹤0.01%	1991
2022 Q4	$3.28K	Buy	189 +144	+320%	+$3.04K	﹤0.01%	2011
2022 Q3	$1K	Buy	45 +16	+55%	+$551	﹤0.01%	2293
2022 Q2	$1K	Buy	+29	New	+$772	﹤0.01%	2199
2022 Q1	–	Sell	-1,469	Closed	-$87K	–	2495
2021 Q4	$87K	Buy	+1,469	New	+$102K	0.01%	525

Other funds holding CYRX

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

TAM

Thematics Asset Management Paris, France $2.2B AUM 18.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Lindbrook Capital's CYRX Position: Q1 2025 in Review

Lindbrook Capital reduced its CryoPort (CYRX) stake by 49% in Q1 2025, selling an estimated $2.44K and leaving 361 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

Lindbrook Capital first reported a position in CYRX in Q4 2021 and has held it in 10 quarters since. The position peaked at $87K in Q4 2021. 153 funds tracked by Wall St. Rank hold CYRX as of Q1 2025.

Lindbrook Capital held 361 shares of CryoPort worth $2.19K as of Q1 2025.
Lindbrook Capital sold 352 CryoPort shares in Q1 2025, an estimated $2.44K.
CryoPort made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2252 holding.
Lindbrook Capital first reported a position in CryoPort in Q4 2021 and has held it in 10 quarters since.
Lindbrook Capital's CryoPort position peaked at $87K in Q4 2021.
153 funds tracked by Wall St. Rank held CryoPort as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.